Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Patrícia Ferreira Ribeiro Delfino"'
Autor:
Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, Camila Piqui Nascimento, Lara de Andrade Marques, Patrícia Ferreira Ribeiro Delfino, Rafael Mathias Antonioli, Rogério Agenor de Araújo, Marcelo José Barbosa Silva
Publikováno v:
ecancermedicalscience. 16
The luminal subtype accounts for ~70% of newly diagnosed breast cancer patients. Although it has a better prognosis, approximately 30% of them develop a late relapse. Identifying those patients is of interest to improve treatment decisions.A retrospe
Autor:
Rogério Agenor de Araújo, Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, Camila Piqui Nascimento, Lara de Andrade Marques, Patrícia Ferreira Ribeiro Delfino, Rafael Mathias Antonioli, Breno Jeha Araújo, Ana Cristina Araújo Lemos da Silva, Maria Luiza Gonçalves dos Reis Monteiro, Morun Bernardino Neto, Marcelo José Barbosa Silva
Publikováno v:
Ecancermedicalscience. 16
Epidermal growth factor receptor (EGFR) overexpression has been considered a poor prognostic factor in breast cancer.A prospective study of 206 women with breast cancer analysed by stages (I, II, III and IV) and by immunohistochemical subtype (Lumina
Autor:
Felipe Andrés Cordero, da Luz, Eduarda, da Costa Marinho, Camila Piqui, Nascimento, Lara, de Andrade Marques, Patrícia Ferreira Ribeiro, Delfino, Rafael Mathias, Antonioli, Rogério Agenor, de Araújo, Marcelo José Barbosa, Silva
Publikováno v:
ecancermedicalscience. 16
Tumour lymphovascular invasion is not routinely assessed in all pathology services, and whether reporting it quantitatively or qualitatively is the main factor associated with the loss of this prognostic event. This study aimed to analyse the prognos
Autor:
Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, Camila Piqui Nascimento, Lara de Andrade Marques, Patrícia Ferreira Ribeiro Delfino, Rafael Mathias Antonioli, Marcelo José Barbosa Silva, Rogério Agenor de Araújo
Publikováno v:
Ecancermedicalscience. 16
Breast cancer is a heterogeneous disease with overexpression of several receptors, such as human epidermal receptor 2 (HER2), which is a prognostic and predictive biomarker for treatment with the anti-HER2 monoclonal antibody trastuzumab. This study
Autor:
Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, Camila Piqui Nascimento, Lara de Andrade Marques, Mateus Bringel Oliveira Duarte, Patrícia Ferreira Ribeiro Delfino, Rafael Mathias Antonioli, Rogério Agenor de Araújo, Marcelo José Barbosa Silva
Publikováno v:
Surgical Oncology. 41:101709
The locoregional management of breast cancer has a critical impact on prognosis. This study aimed to analyze the effectiveness of radiotherapy against the deleterious effect of positive surgical margins on disease outcomes.Retrospective, single-cente